Monoclonal Antibody Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00003417
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Monoclonal Antibody Therapeutics (mABs) Market - Scope 2031

Buy Now

Monoclonal Antibody Therapeutics (mABs) Market Report Monoclonal Antibody Therapeutics (mABs) Market Size and Share Monoclonal Antibody Therapeutics (mABs) Market Scope and Analysis

Monoclonal Antibody Therapeutics (mABs) Market Report Scope

Report Attribute Details
Market size in 2024 249.14 Million
Market Size by 2031 619.60 Million
Global CAGR (2024 - 2031) 13.9%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Recombinant mABs
  • Antibody Drug Conjugates
  • Bispecific and Multispecific mABs
  • Biosimilars
By Application
  • Oncology
  • Autoimmune Disease
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GlaxoSmithKline
  • F Hoffmann La Roche
  • Bayer AG
  • Amgen
  • Novartis
  • AbbVie
  • Bristol Myers Squibb
  • Janssen Pharmaceutical
  • Merck KgaA
  • AstraZeneca
    		•